ライフサイエンスコーパス: fundus autofluorescence

1 t, visibility on funduscopy, ultrasound, and fundus autofluorescence.

2 ation plots), SD-OCT, and sometimes mfERG or fundus autofluorescence.

3 ger wavelengths, a characteristic typical of fundus autofluorescence.

4 n retinal diseases characterized by aberrant fundus autofluorescence.

5 g the growth of atrophic lesions measured by fundus autofluorescence.

6 diameter of a paracentral ring of increased fundus autofluorescence.

7 cidence of atrophic lesions as determined by fundus autofluorescence.

8 ral-domain optical coherence tomography, and fundus autofluorescence.

9 Fundus autofluorescence (AF) images (55 degrees lens, 48

10 on assessment, color fundus photography, and fundus autofluorescence (AF) imaging.

11 Measures of retinal structure and fundus autofluorescence (AF) were correlated with visual

12 visual acuity (BCVA), widefield angiography, fundus autofluorescence (AF), and wnt signaling pathway

13 surements using two techniques (2-wavelength fundus autofluorescence [AF] and heterochromatic flicker

14 main optical coherence tomography (OCT), and fundus autofluorescence analysis were performed in patie

15 Fundus autofluorescence and electrophysiological testing

16 and optical coherence tomography (along with fundus autofluorescence and multifocal electroretinograp

17 ence tomography features and staging system, fundus autofluorescence and near-infrared reflectance fe

18 Fundus autofluorescence and optical coherence tomography

19 Newer imaging modalities such as fundus autofluorescence and spectral domain optical cohe

20 derwent best-corrected visual acuity (BCVA), fundus autofluorescence and spectral domain-optical cohe

21 e evaluated the multimodal imaging including fundus autofluorescence and spectral-domain optical cohe

22 ed the foveal attenuation normally seen with fundus autofluorescence, and a concentric macular rings

23 infrared reflectance, hypoautofluorescent on fundus autofluorescence, and as subretinal deposits on s

24 ptic nerve head (ONH), infrared reflectance, fundus autofluorescence, and color fundus photographs (C

25 rimetry, optical coherence tomography (OCT), fundus autofluorescence, and fundus photography.

26 color photography, fluorescein angiography, fundus autofluorescence, and high-resolution optical coh

27 ncluding optical coherence tomography (OCT), fundus autofluorescence, and indocyanine green and fluor

28 l field, and full-field electroretinography, fundus autofluorescence, and optical coherence tomograph

29 Fluorescein angiography, fundus autofluorescence, and optical coherence tomograph

30 color photography, fluorescein angiography, fundus autofluorescence, and optical coherence tomograph

31 Color fundus photographs, fundus autofluorescence, and spectral-domain OCT were ob

32 ering) could produce a cross-shaped increase fundus autofluorescence artifact on subsequent imaging.

33 ral color fundus and optic disc photography, fundus autofluorescence, automated perimetry, and optica

34 n area of increased autofluorescence on blue fundus autofluorescence (B-FAF).

35 coherence tomography (FD-OCT) and blue-light fundus autofluorescence (bAF).

36 visual acuity with ETDRS charts, blue-light fundus autofluorescence, (BL-FAF), near-infrared fundus

37 o short-wavelength light resulted in reduced fundus autofluorescence, decreased HPLC-quantified A2E,

38 Fundus autofluorescence demonstrated mild hyperautofluor

39 Fundus autofluorescence disclosed hypoautofluorescence (

40 Fundus autofluorescence (FAF) and color fundus (CF) phot

41 he enlargement of the atrophic lesions using fundus autofluorescence (FAF) and color fundus photograp

42 coherence tomography (OCT), OCT-Angiography, fundus autofluorescence (FAF) and fluorescein-angiograph

43 almoscopy, and fundus photography, including fundus autofluorescence (FAF) and near-infrared reflecta

44 basis of full-field electroretinogram (ERG) Fundus autofluorescence (FAF) and spectral domain-optica

45 jective corroboration for visual fields, and fundus autofluorescence (FAF) can show damage topographi

46 Fundus autofluorescence (FAF) decays were detected in sh

47 ion algorithm and correlated with SD OCT and fundus autofluorescence (FAF) findings.

48 Eyes were evaluated on fundus autofluorescence (FAF) for GA.

49 The 200 degrees pseudocolor and fundus autofluorescence (FAF) images were captured on th

50 acula volume scans centered at the fovea and fundus autofluorescence (FAF) images were obtained.

51 Fundus autofluorescence (FAF) imaging and optical cohere

52 s photography, optical coherence tomography, fundus autofluorescence (FAF) imaging, and audiologic an

53 l-domain optical coherence tomography (OCT), fundus autofluorescence (FAF) imaging, full-field electr

54 Electrophysiological assessment, fundus autofluorescence (FAF) imaging, fundus fluorescei

55 l-domain optical coherence tomography (OCT), fundus autofluorescence (FAF) imaging, Humphrey visual f

56 s photography, fluorescein angiography (FA), fundus autofluorescence (FAF) imaging, optical coherence

57 us photography, near-infrared (NIR) imaging, fundus autofluorescence (FAF) imaging, spectral domain o

58 logic examination, color fundus photography, fundus autofluorescence (FAF) imaging, spectral-domain (

59 In all probands, fundus autofluorescence (FAF) imaging, spectral-domain o

60 thalmologic examination, fundus photography, fundus autofluorescence (FAF) imaging, spectral-domain o

61 Characteristics of GA were examined using fundus autofluorescence (FAF) imaging.

62 n optical coherence tomography (SD-OCT), and fundus autofluorescence (FAF) imaging.

63 ain optical coherence tomography (SDOCT) and fundus autofluorescence (FAF) imaging.

64 in optical coherence tomography (SD OCT) and fundus autofluorescence (FAF) imaging.

65 sed primarily by color fundus photography or fundus autofluorescence (FAF) imaging.

66 n enlargement from baseline as assessed with fundus autofluorescence (FAF) imaging.

67 contribution of retro-mode imaging (RMI) and fundus autofluorescence (FAF) to the characterization of

68 omain optical coherence tomography (SD OCT), fundus autofluorescence (FAF), and fluorescein angiograp

69 rimetry, optical coherence tomography (OCT), fundus autofluorescence (FAF), and fundus photography.

70 omain optical coherence tomography (SD-OCT), fundus autofluorescence (FAF), and infrared reflectance

71 with conventional multimodal imaging (color, fundus autofluorescence (FAF), and infrared reflectance

72 ear-infrared (NIR) and short-wavelength (SW) fundus autofluorescence (FAF), and NIR reflectance (REF)

73 ompared with automated visual fields (AVFs), fundus autofluorescence (FAF), and optical coherence tom

74 ded 35 degrees fundus photography, infrared, fundus autofluorescence (FAF), and SD-OCT.

75 tion together with color fundus photography, fundus autofluorescence (FAF), and spectral-domain optic

76 ude color fundus photography (CFP), confocal fundus autofluorescence (FAF), confocal near-infrared re

77 plete ophthalmological examination including fundus autofluorescence (FAF), dynamic simultaneous fluo

78 undus examination, color fundus photographs, fundus autofluorescence (FAF), fluorescein angiography (

79 (BCVA), ophthalmoscopy, fundus photography, fundus autofluorescence (FAF), fluorescein angiography (

80 ct ophthalmoscopy, color fundus photography, fundus autofluorescence (FAF), high-resolution optical c

81 thalmologic examination, fundus photography, fundus autofluorescence (FAF), infrared imaging, and spe

82 chart, fundus photography, ultrasonography, fundus autofluorescence (FAF), infrared reflectance (IR)

83 ng best-corrected visual acuity (BCVA), blue fundus autofluorescence (FAF), near-infrared autofluores

84 uding color and red-free fundus photography, fundus autofluorescence (FAF), near-infrared reflectance

85 fundus photography, fluorescein angiography, fundus autofluorescence (FAF), near-infrared reflectance

86 omain optical coherence tomography (SD OCT), fundus autofluorescence (FAF), or multifocal electroreti

87 uscin accumulation, as measured by increased fundus autofluorescence (FAF), precedes progression or d

88 visits for at least 1 examination modality: fundus autofluorescence (FAF), spectral-domain (SD) opti

89 gment epithelium (RPE) is the main source of fundus autofluorescence (FAF), the target of an imaging

90 rimetry, full-field electroretinography, and fundus autofluorescence (FAF).

91 omain ocular coherence tomography (OCT), and fundus autofluorescence (FAF).

92 in all 7 patients, corresponding to abnormal fundus autofluorescence (FAF).

93 in optical coherence tomography (SD OCT) and fundus autofluorescence (FAF).

94 ected visual acuity (BCVA) determination and fundus autofluorescence (FAF).

95 Eyes were examined longitudinally with fundus autofluorescence (FAF; excitation wavelength, 488

96 [SD] optical coherence tomography [OCT], and fundus autofluorescence [FAF]) then were reviewed.

97 Optical coherence tomography and fundus autofluorescence findings suggest that group V ph

98 ng system of SC lesions based on SS-OCTA and fundus autofluorescence findings.

99 fundus imaging, including color photographs, fundus autofluorescence, fluorescein angiography, and in

100 r detachments based on clinical examination, fundus autofluorescence, fluorescein angiography, and op

101 ubmaculopathy based on clinical examination, fundus autofluorescence, fluorescein angiography, and sp

102 ation, fundus photography, infrared imaging, fundus autofluorescence, fluorescein angiography, and sp

103 Fundus autofluorescence (fundus AF) changes were monitor

104 The fundus autofluorescence generally represents the status

105 reen angiography, near-infrared reflectance, fundus autofluorescence, high-resolution OCT, and ultraw

106 east 1 eye at the most recent visit, and (2) fundus autofluorescence images for at least 2 visits wit

107 A series of 3 fundus autofluorescence images using 3 different acquisi

108 Fundus autofluorescence images were not available.

109 these patients, 215 had at least 2 gradable fundus autofluorescence images with atrophic lesion(s) p

110 tofluorescent AZOOR line in short-wavelength fundus autofluorescence images, delineating the peripapi

111 fundus examination, Goldmann visual fields, fundus autofluorescence imaging (FAF), optical coherence

112 Fundus autofluorescence imaging and optical coherence to

113 responded to hyperautofluorescent lesions on fundus autofluorescence imaging and subretinal hyperrefl

114 Fundus autofluorescence imaging can reveal the extent of

115 a normal retinal appearance, although their fundus autofluorescence imaging demonstrated foci of inc

116 optical coherence tomography and to describe fundus autofluorescence imaging in this condition.

117 Fundus autofluorescence imaging is abnormal in children

118 The electrophysiological and fundus autofluorescence imaging presented here should fa

119 Fundus autofluorescence imaging remained normal.

120 Fundus autofluorescence imaging showed a parafoveal annu

121 elength reduced-illuminance and conventional fundus autofluorescence imaging showed good concordance

122 Fundus autofluorescence imaging was not used.

123 Fundus autofluorescence imaging was used to evaluate GA

124 graphy (CFP), near-infrared reflectance, and fundus autofluorescence imaging were performed in all pa

125 uorescein and indocyanine green angiography, fundus autofluorescence imaging, and corresponding eye-t

126 l-domain optical coherence tomography (OCT), fundus autofluorescence imaging, and electroretinogram (

127 eld electroretinography, fundus photography, fundus autofluorescence imaging, and optical coherence t

128 clinically by wide-field color photography, fundus autofluorescence imaging, and spectral-domain opt

129 linical examination, fundus photography, and fundus autofluorescence imaging, and visual function was

130 and detailed retinal imaging was performed: fundus autofluorescence imaging, digital color fundoscop

131 tance, red-free images and blue reflectance, fundus autofluorescence imaging, indocyanine green angio

132 fundus examination, wide-field photography, fundus autofluorescence imaging, sedated electroretinogr

133 ral-domain optical coherence tomography, and fundus autofluorescence imaging.

134 main optical coherence tomography (OCT), and fundus autofluorescence imaging.

135 tral domain optical coherence tomography and fundus autofluorescence imaging.

136 ents with Stargardt disease as determined by fundus autofluorescence imaging.

137 produced a striking leopard-spot pattern on fundus autofluorescence imaging.

138 ated with marked loss of autofluorescence on fundus autofluorescence imaging.

139 ve on NIR reflectance and hypofluorescent on fundus autofluorescence imaging.

140 The dots were hyperautofluorescent on fundus autofluorescence imaging.

141 ded by a continuous hyperfluorescent ring on fundus autofluorescence imaging.

142 We assessed the utility of quantified fundus autofluorescence in (FAF) the evaluation and foll

143 We assessed the utility of quantification of fundus autofluorescence in the evaluation and follow-up

144 Most importantly, we also observed reduced fundus autofluorescence in the eyes injected with NP and

145 chart, fundus photography, ultrasonography, fundus autofluorescence, infrared reflectance (IR) imagi

146 ield and pattern), visual evoked potentials, fundus autofluorescence IRR, and optical coherence tomog

147 Fundus autofluorescence is a helpful, fast, and noninvas

148 Fundus autofluorescence is a noninvasive technique for e

149 n area was larger than both the ONL-slab and fundus autofluorescence lesion areas.

150 In Stargardt disease with DDAF lesions, fundus autofluorescence may serve as a monitoring tool f

151 pectral-domain optical coherence tomography, fundus autofluorescence, multifocal electroretinography,

152 Other methods, including fundus autofluorescence, near-infrared reflectance, and

153 us autofluorescence, (BL-FAF), near-infrared fundus autofluorescence (NIR-FAF), and RMI.

154 graphy (OCT), en face near-infrared imaging, fundus autofluorescence, optical coherence tomography an

155 Interestingly, no changes in macular fundus autofluorescence pattern were evident after optic

156 Quantitative fundus autofluorescence (qAF) and spectral-domain optica

157 length fundus autofluorescence (quantitative fundus autofluorescence [qAF]) and spectral-domain optic

158 ndus lesions by quantifying short-wavelength fundus autofluorescence (quantitative fundus autofluores

159 Fundus autofluorescence showed little or no change excep

160 ite 10-2 visual field pattern density plots, fundus autofluorescence, spectral-density optical cohere

161 nce tomography (SD-OCT) and short wavelength fundus autofluorescence (SW-AF).

162 idenced by HPLC analysis and quantitation of fundus autofluorescence; this effect is consistent with

163 pth imaging (EDI)-OCT, swept source OCT, and fundus autofluorescence using a fundus camera.

164 aluate the disease extent on ultra-widefield fundus autofluorescence (UWF-FAF) in patients with ABCA4

165 CI, 0.42-0.61 mm2/y), and of total decreased fundus autofluorescence was 0.35 mm2/y (95% CI, 0.28-0.4

166 f patients exhibiting annular RPE lesions on fundus autofluorescence was included for chart review an

167 Repeat fundus autofluorescence was obtained at 12, 24, 36, and

168 Fundus autofluorescence was quantified (qAF) in subjects

169 No significant increases of fundus autofluorescence were detected by SLO imaging of

170 uding optical coherence tomography (OCT) and fundus autofluorescence were evaluated at the baseline a

171 tients, and optical coherence tomography and fundus autofluorescence were performed in 4 patients.

172 ncluding near-infrared (NIR) reflectance and fundus autofluorescence with a confocal scanning laser o